NeuroMetrix Showcases Quell® Technology at the American Academy of Pain Medicine Annual Meeting

The Only FDA Cleared 24/7 Wearable for Chronic Pain Relief

WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ:NURO) today announced that Quell Wearable Pain Relief Technology™ will be featured at the American Academy of Pain Medicine (AAPM) Annual Meeting in Palm Springs, California at the Palm Springs Convention Center on February 18-21.

"With over 100 million Americans suffering from chronic pain, and many of them getting inadequate relief from their pain medications or suffering side effects, there are significant unmet needs in pain management," said Shai N. Gozani, M.D., Ph.D., President and Chief Executive Officer of NeuroMetrix. "We are pleased to take part in the AAPM annual meeting and will share the role that Quell's innovative technology can play in the management of chronic pain. Quell is a new 100% drug free technology that addresses a variety of chronic pain conditions. Patients can wear it 24/7 and continue to derive therapeutic benefit even while sleeping."

About Quell

Quell utilizes NeuroMetrix's patented neurostimulation technology to provide widespread relief from chronic pain. The advanced wearable device is lightweight and can be worn during the day while active, and at night while sleeping. It has been cleared by the FDA for treatment of chronic pain. In a recent study, 81% of Quell users reported an improvement in their chronic pain. Quell includes a smartphone app that tracks and personalizes their pain therapy. It is available for purchase at QuellRelief.com, selected retailers and healthcare professionals.

About the American Academy of Pain Medicine

Founded in 1983, the American Academy of Pain Medicine (AAPM) is the premier scientific and educational association for pain physicians and their treatment teams. The AAPM has a membership of nearly 2,400 medical professionals.

About NeuroMetrix

NeuroMetrix is an innovative healthcare company that develops wearable medical technology and point-of-care tests that help patients and physicians better manage chronic pain, nerve diseases, and sleep disorders. The company is located in Waltham, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996. For more information, please visit www.NeuroMetrix.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160210005331/en/

NeuroMetrix, Inc.
Thomas T. Higgins, 781-314-2761
SVP and Chief Financial Officer
neurometrix.ir@neurometrix.com

Source: NeuroMetrix, Inc.

News Provided by Acquire Media